Table 1 of
Micheal, Mol Vis 2014; 20:1471-1479. Table 1 of
Micheal, Mol Vis 2014; 20:1471-1479.
Table 1. Genotype frequencies in patients and controls.
| Genotypes | Patients n=513 (%) | Controls n=233 (%) | p (χ2) | p (χ2) | OR (95% CI) |
|---|---|---|---|---|---|
| CDKN2B-AS1 rs4977756 | |||||
| AA | 281 (54.7) | 135 (57.9) | 0.63 (0.91) | Reference | |
| AG | 197 (38.5) | 81 (34.8) | 0.35 (0.85) | 0.86 (0.61–1.21) | |
| GG | 35 (6.8) | 17 (7.3) | 0.97 (0.00) | 0.99 (0.51–1.92) | |
| CDKN2B rs1063192 | |||||
| TT | 270 (52.6) | 127 (54.5) | 0.87 (0.26) | Reference | |
| CT | 206 (40.2) | 89 (38.2) | 0.60 (0.26) | 0.92 (0.65–1.29) | |
| CC | 37 (7.2) | 17 (7.3) | 0.94 (0.01) | 0.98 (0.51–1.87) | |
| ATOH7 rs1900004 | |||||
| CC | 230 (44.9) | 110 (47.2) | 0.75 (0.57) | Reference | |
| CT | 231 (45.0) | 98 (42.1) | 0.47 (0.51) | 0.89 (0.63–1.25) | |
| TT | 52 (10.1) | 25 (10.7) | 0.98 (0.00) | 0.99 (0.57–1.75) | |
| CAV1 rs4236601 | |||||
| GG | 296 (57.7) | 150 (64.4) | 0.06 (5.45) | Reference | |
| AG | 183 (35.7) | 76 (32.6) | 0.23 (1.38) | 0.82 (0.58–1.16) | |
| AA | 34 (6.6) | 7 (3.0) | 0.02 (4.71) | 2.46 (1.01–6.24) | |
| TMCO1 rs4656461 | |||||
| AA | 420 (81.9) | 162 (69.5) | <0.0001 (14.32) | Reference | |
| AG | 91 (17.7) | 69 (29.6) | <0.001 (13.68) | 0.51 (0.35–0.74) | |
| GG | 2 (0.4) | 2 (0.9) | 0.32 (0.97) | 0.39 (0.04–3.86) | |
| SIX1 rs10483727 | |||||
| CC | 104 (20.3) | 46 (19.7) | 0.64 (0.87) | Reference | |
| CT | 261 (50.9) | 112 (48.1) | 0.88 (0.02) | 0.97 (0.63–1.50) | |
| TT | 148 (28.8) | 75 (32.2) | 0.54 (0.36) | 0.87 (0.55–1.39) | |